List of bibliographic references
Number of relevant bibliographic references: 25.
[0-20] [
0 - 20][
0 - 25][
20-24][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000136 (2020) |
J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine] | [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]. |
| 000181 (2020) |
Haiou Li [République populaire de Chine] ; Yunjiao Zhou [République populaire de Chine] ; Meng Zhang [République populaire de Chine] ; Haizhou Wang [République populaire de Chine] ; Qiu Zhao [République populaire de Chine] ; Jing Liu [République populaire de Chine] | Updated approaches against SARS-CoV-2. |
| 000220 (2020) |
Robert L. Kruse [États-Unis] | Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. |
| 000226 (2020) |
Philip Hunter [Royaume-Uni] | The spread of the COVID-19 coronavirus: Health agencies worldwide prepare for the seemingly inevitability of the COVID-19 coronavirus becoming endemic. |
| 000270 (2020) |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. |
| 000317 (2020) |
Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde] | Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). |
| 000370 (2020) |
Kit-San Yuen [Hong Kong] ; Zi Wei Ye [Hong Kong] ; Sin-Yee Fung [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | SARS-CoV-2 and COVID-19: The most important research questions |
| 000421 (2020) |
Anh-Tien Ton [Canada] ; Francesco Gentile [Canada] ; Michael Hsing [Canada] ; Fuqiang Ban [Canada] ; Artem Cherkasov [Canada] | Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. |
| 000467 (2020) |
Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. |
| 000480 (2020) |
Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
| 000488 (2020) |
Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine] | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. |
| 000509 (2020) |
Xiangdong Chen ; Yanhong Liu ; Yahong Gong ; Xiangyang Guo ; Mingzhang Zuo ; Jun Li ; Wenzhu Shi ; Hao Li ; Xiaohan Xu ; Weidong Mi ; Yuguang Huang | Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. |
| 000670 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
| 000706 (2020) |
Shweta Saraswat ; Meenakshi Chaudhary ; Deepak Sehgal | Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays |
| 000748 (2020) |
Atte Sandelin [Finlande] ; Heidi H Rtel ; Leena Sepp Lassila [Finlande] ; Liisa Kaartinen [Finlande] ; Helena Rautala [Finlande] ; Timo Soveri [Finlande] ; Heli Simojoki [Finlande] | Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit |
| 000825 (2020) |
Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
| 000902 (2020) |
Owen Dyer | Covid-19: Trump sought to buy vaccine developer exclusively for US, say German officials. |
| 000975 (2020) |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
| 000A45 (2020) |
Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] | Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine |
| 000A82 (2020) |
Silvia Angeletti [Italie] ; Domenico Benvenuto [Italie] ; Martina Bianchi [Italie] ; Marta Giovanetti [Brésil] ; Stefano Pascarella [Italie] ; Massimo Ciccozzi [Italie] | COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. |
| 000B27 (2020) |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i -k "vaccine"
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i \
-Sk "vaccine" \
| HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= an2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= vaccine
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021 |  |
